Frontlight ResearchEarly access
Trial site
Prisma Health Cancer Institute, ITOR, CRU
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer2 trials
- Colorectal cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 32 trials
- Phase 1/21 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.2 trials
- Daiichi Sankyo1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026